GSK-1070806

N/A

Report date: 2025/11/18 20:00:06

Base Information

Drug NameGSK-1070806
Drug Alias NameGSK-1070806
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionInterleukin 18 inhibitors
TargetsInterleukin 18
Therapy Area/IndicationsRejection of renal transplantationDiabetes MellitusDermatitis, Atopic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[18] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Intellectual Property Development Ltd
Inactive CompaniesGlaxosmithkline PlcGlaxosmithkline Research & Development LtdGlaxosmithkline Llc +[5] 
Active IndicationsDermatitis, Atopic
Inactive IndicationsRejection of renal transplantationDiabetes MellitusCrohn Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A